Intellectual Thoughts by Sanjay Panda !!!!!: Ranbaxy US unit gets a violation notice


Thursday, December 24, 2009

Ranbaxy US unit gets a violation notice

Ranbaxy Laboratories Ltd said on 24th Dec that's its wholly-owned US-based unit Ohm Laboratories Inc has received a warning letter from the US Food and Drug Administration (FDA) relating to violations of good manufacturing practices. The FDA letter, dated December 21, mentions violations at Ohm's liquid manufacturing facility in Gloversville, New York,

The FDA conducted site inspections at the plant in July and August 2009. Ohm Laboratories operates three US-based manufacturing facilities and sells generic and branded private label drugs in the United States.

Ranbaxy said the FDA inspected Ohm's other two plants earlier this year but did not observe any material deviations.Late last year, Ranbaxy had received a US ban on some of its products.

No comments: